Structure and Function of C. Difficile Toxins
艰难梭菌毒素的结构和功能
基本信息
- 批准号:9913462
- 负责人:
- 金额:$ 80.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-15 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffinityBasic ScienceBindingBiologyBontoxilysinCRISPR/Cas technologyCell modelCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeClostridium difficileClostridium difficile tcdA proteinColitisCollaborationsComplementComplexCrystallizationCustomDataDeveloped CountriesDevelopmentDiarrheaDiseaseDockingEpithelialEpitheliumExhibitsExotoxinsFZD1 geneFZD2 geneFatty AcidsGastroenteritisGoalsHeparitin SulfateHumanInfectionInvestigationKnowledgeLengthLipoprotein (a)Low Density Lipoprotein ReceptorMass Spectrum AnalysisMediatingModelingMolecularMusMutagenesisNonesterified Fatty AcidsOrganoidsPathogenesisPathogenicityPathway interactionsProteinsPublishingReceptor CellResearchRoleSeriesSiteStructural ModelsStructureTherapeutic InterventionToxic effectToxinTropismWNT Signaling PathwayWorkalpha Toxinantibiotic-associated diarrheacrosslinkdesignexperimental studygenome wide screeninsightinterdisciplinary approachmembermolecular targeted therapiesmultidisciplinarymutantnovelnovel therapeutic interventionreceptorreceptor bindingresearch studysmall moleculetargeted treatmenttherapeutic developmenttooltranslational study
项目摘要
Project Summary
Clostridium difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea
and gastroenteritis-associated death among developed countries, and it is classified as one of
the top three “urgent threats” by the US Centers for Disease Control and Prevention (CDC). The
disease associated with CDI is mainly mediated by two homologous exotoxins, TcdA and TcdB.
They target and disrupt the colonic epithelium, leading to diarrhea and colitis. Receptor-binding
is a critical step in the toxin’s action and largely determine toxin tropisms, and these receptors
are also molecular targets for therapeutic interventions. The goal of our proposal is to identify
and characterize toxin receptors, establish a structural basis for toxin-receptor recognition, and
harness this knowledge to gain a mechanistic understanding of the biology, pathogenesis, and
therapy of TcdA and TcdB. We will take a multi-disciplinary approach, bringing together the
expertise in toxin structure/function of Dr. Rongsheng Jin’s group with the expertise in toxin
receptor identification/pathogenesis of Dr. Min Dong’s group. This proposed work is built on
both our published work on identifying Frizzled (FZD) proteins as TcdB receptors, and extensive
preliminary data on toxin-receptor interactions. We will focus on three aims: (1) elucidate the
structural basis and pathogenic relevance of TcdB-FZD recognition;; (2) understand the structure
of TcdB and the influence of FZD binding;; and (3) identify and characterize novel TcdA
receptors through a CRISPR/Cas9 mediated genome-wide screens. These proposed studies
will provide a comprehensive understanding of toxin-receptor interactions and how they
contribute to the toxin biology and pathogenesis of TcdA and TcdB.
项目摘要
艰难梭菌感染(CDI)是抗生素相关腹泻的最常见原因
以及发达国家胃肠炎相关的死亡,并被归类为
美国疾病控制与预防中心(CDC)的前三名“紧急威胁”。这
与CDI相关的疾病主要由两种同源外毒素TCDA和TCDB介导。
它们靶向并破坏结肠上皮,导致腹泻和结肠炎。受体结合
是毒素作用的关键步骤,并在很大程度上决定了毒素的偏向主义,这些接收器
也是治疗干预措施的分子靶标。我们建议的目的是确定
并表征毒素受体,建立毒素受体识别的结构基础,然后
利用这些知识对生物学,发病机理和
TCDA和TCDB的治疗。我们将采用多学科的方法,将
Rongsheng Jin博士的毒素结构/功能专业知识,具有毒素专业知识
Min Dong博士小组的接收者鉴定/发病机理。这项建议的工作建立在
我们发表的有关将毛躁(FZD)蛋白识别为TCDB受体的工作和广泛的
毒素受体相互作用的初步数据。我们将重点关注三个目标:(1)阐明
TCDB-FZD识别的结构巴西语和致病性相关性; (2)了解结构
TCDB和FZD结合的影响; (3)识别和表征新型TCDA
通过CRISPR/CAS9介导的全基因组屏幕的接收器。这些提出的研究
将对毒素受体相互作用以及如何提供全面的理解
有助于TCDA和TCDB的毒素生物学和发病机理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Min Dong其他文献
Min Dong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Min Dong', 18)}}的其他基金
Genome-wide CRISPR-Cas9 screens in insect cells to characterize insecticidal toxins
在昆虫细胞中进行全基因组 CRISPR-Cas9 筛选以表征杀虫毒素
- 批准号:
10873497 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
- 批准号:
10382052 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Genome-wide CRISPR-Cas9 screens in insect cells to characterize insecticidal toxins
在昆虫细胞中进行全基因组 CRISPR-Cas9 筛选以表征杀虫毒素
- 批准号:
10502624 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
- 批准号:
10551233 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Model-Informed Evaluation of Hydroxyurea Exposure in Special Populations
特殊人群羟基脲暴露的模型知情评估
- 批准号:
10653016 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Genome-wide CRISPR-Cas9 screens in insect cells to characterize insecticidal toxins
在昆虫细胞中进行全基因组 CRISPR-Cas9 筛选以表征杀虫毒素
- 批准号:
10646295 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Model-Informed Evaluation of Hydroxyurea Exposure in Special Populations
特殊人群羟基脲暴露的模型知情评估
- 批准号:
10427738 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Targeted delivery of therapeutics into motor neurons for post-exposure treatment of botulism
将治疗药物靶向输送至运动神经元,用于肉毒杆菌中毒的暴露后治疗
- 批准号:
10453725 - 财政年份:2021
- 资助金额:
$ 80.4万 - 项目类别:
Targeted delivery of therapeutics into motor neurons for post-exposure treatment of botulism
将治疗药物靶向输送至运动神经元,用于肉毒杆菌中毒的暴露后治疗
- 批准号:
10210524 - 财政年份:2021
- 资助金额:
$ 80.4万 - 项目类别:
Targeted Delivery of Therapeutics into Motor Neurons for Post-exposure Treatment of Botulism
将治疗药物靶向输送至运动神经元,用于肉毒杆菌中毒的暴露后治疗
- 批准号:
10653914 - 财政年份:2021
- 资助金额:
$ 80.4万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Antibody-based therapy for fentanyl-related opioid use disorder
基于抗体的芬太尼相关阿片类药物使用障碍治疗
- 批准号:
10831206 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Mechanisms and manipulation of force dependent behavior in T cell biology
T 细胞生物学中力依赖性行为的机制和操纵
- 批准号:
10681766 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Elucidation and improved control of human induced pluripotent stem cell cardiac differentiation by using single-guide RNA-based cellular barcoding to track and manipulate lineages
通过使用基于单向导 RNA 的细胞条形码来跟踪和操纵谱系,阐明并改进对人类诱导多能干细胞心脏分化的控制
- 批准号:
10752369 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
- 批准号:
10720245 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
ST6GalNAc-I/MUC5AC promoting angiogenesis in lung adenocarcinoma
ST6GalNAc-I/MUC5AC促进肺腺癌血管生成
- 批准号:
10513140 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别: